Associations Between Metabolic Syndrome and Long-Term Mortality in Patients who underwent Percutaneous Coronary
Joseph M O'Brien1, Diem Dinh2, Louise Roberts1
1Department of Cardiology, Eastern Health, Box Hill, Victoria, Australia.
The American Journal of Cardiology
|March 6, 2024
Summary
Metabolic syndrome (MetS) affects one in three patients undergoing percutaneous coronary intervention (PCI). While associated with higher mortality initially, MetS is not an independent predictor of long-term outcomes after PCI.
Area of Science:
- Cardiovascular Medicine
- Metabolic Disorders
- Interventional Cardiology
Background:
- Metabolic syndrome (MetS) significantly increases coronary heart disease risk.
- Long-term prognosis following percutaneous coronary intervention (PCI) in MetS patients remains understudied.
- Understanding MetS impact on PCI outcomes is crucial for patient management.
Purpose of the Study:
- To assess the prevalence of MetS in an Australian PCI cohort.
- To compare 30-day outcomes and long-term mortality between patients with and without MetS post-PCI.
- To evaluate MetS as an independent predictor of long-term mortality after PCI.
Main Methods:
- Retrospective analysis of the Melbourne Interventional Group multicenter PCI registry (n=41,146).
- Modified MetS definition: ≥3 of hypertension, diabetes mellitus, dyslipidemia, or BMI ≥30 kg/m².
- Cox regression analysis for multivariable effect of MetS on long-term mortality.
Main Results:
- MetS prevalence was 34% (12,228 patients).
- MetS patients had higher 30-day myocardial infarction rates (2.2% vs 1.8%).
- Long-term mortality was higher in MetS patients (24% vs 19%), but MetS was not an independent predictor after adjustment (HR 0.95, p=0.35).
- MetS-Diabetic patients had highest mortality; MetS-NonDiabetic obese patients had lowest.
- Diabetes mellitus strongly associated with long-term mortality.
Conclusions:
- MetS is common in PCI patients and associated with worse short-term outcomes and higher crude long-term mortality.
- After adjusting for confounders, MetS is a marker rather than an independent predictor of long-term mortality post-PCI.
- Findings support the obesity paradox and highlight the significant impact of diabetes mellitus on long-term PCI outcomes.
Related Concept Videos
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:30Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...